Theriva Biologics, Inc. TOVX

Full chart Compare
Set alert

Price alert · TOVX

All alert types
0.19 USD +0.01 (+4.40%)

At closeNov 5, 2026, 7:45 AM EST

0.19 -0.01 -2.63%

Pre-market · Nov 5, 7:45 AM ET

0.1764 Day range 0.1992
0.14 52-week range 0.49
YTD
-9.52%
1 year
-36.67%

Financial health

Altman Z-Score

-15.43 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 5

Valuation

P/E -0.1×
FY 2016: -65.9×FY 2017: -104×FY 2018: -6.5×FY 2019: -13.9×FY 2020: -14.5×FY 2021: -35.8×FY 2022: -0.3×FY 2023: -0.4×FY 2024: -0.1×FY 2025: -0.1×
FY 2016 5y median -0.3× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016: 467×FY 2017: -1055×FY 2018: 3.0×FY 2019: 14.5×FY 2020: 22.7×FY 2021: 12.7×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
P/FCF -0.2×
FY 2016: -63.1×FY 2017: -77.3×FY 2018: -5.0×FY 2019: -15.0×FY 2020: -14.9×FY 2021: -64.3×FY 2022: -0.4×FY 2023: -0.4×FY 2024: -0.1×FY 2025: -0.2×
FY 2016 5y median -0.4× FY 2025
EV/EBITDA 0.3×
FY 2016: -45.4×FY 2017: -60.0×FY 2018: -3.4×FY 2019: -12.6×FY 2020: -17.7×FY 2021: -53.8×FY 2022: 1.7×FY 2023: 0.6×FY 2024: 0.4×FY 2025: 0.3×
FY 2016 5y median 0.4× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -653.9%
FY 2016: -1.6%FY 2017: -1.3%FY 2018: -19.8%FY 2019: -6.7%FY 2020: -6.7%FY 2021: -1.6%FY 2022: -275.4%FY 2023: -277.3%FY 2024: -717.9%FY 2025: -653.9%
FY 2016 5y median -277.3% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -164.1%
FY 2016: -708.8%FY 2017: 1014.3%FY 2018: -45.5%FY 2019: -106.5%FY 2020: -125.1%FY 2021: -21.8%FY 2022: -36.1%FY 2023: -46.2%FY 2024: -134.5%FY 2025: -164.1%
FY 2016 5y median -46.2% FY 2025
ROIC -52.1%
FY 2016: -1432.0%FY 2017: -290.2%FY 2018: -65.7%FY 2019: -128.3%FY 2020: -177.3%FY 2021: -21.3%FY 2022: -30.9%FY 2023: -40.1%FY 2024: -92.9%FY 2025: -52.1%
FY 2016 5y median -40.1% FY 2025
ROA -66.0%
FY 2016: -121.1%FY 2017: -80.5%FY 2018: -44.3%FY 2019: -88.8%FY 2020: -119.4%FY 2021: -20.3%FY 2022: -27.4%FY 2023: -33.2%FY 2024: -72.6%FY 2025: -66.0%
FY 2016 5y median -33.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 43.0%
FY 2016: 4.2%FY 2017: 33.1%FY 2018: 33.1%FY 2019: 10.9%FY 2020: 35.1%FY 2021: -40.5%FY 2022: -51.2%FY 2023: 0.7%FY 2024: -22.9%FY 2025: 43.0%
FY 2016 FY 2025
EPS (diluted) 89.1%
FY 2016: 46.7%FY 2017: 57.8%FY 2018: 49.8%FY 2019: 57.4%FY 2020: 27.8%FY 2021: 71.2%FY 2022: -1618.9%FY 2023: 12.8%FY 2024: 33.2%FY 2025: 89.1%
FY 2016 FY 2025
Free Cash Flow 1.4%
FY 2016: 27.7%FY 2017: 28.3%FY 2018: 15.3%FY 2019: 19.7%FY 2020: 12.2%FY 2021: -6.0%FY 2022: -48.8%FY 2023: 0.0%FY 2024: 11.8%FY 2025: 1.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.7×
FY 2016: 1.1×FY 2017: 1.8×FY 2018: 8.7×FY 2019: 3.1×FY 2020: 2.7×FY 2021: 19.4×FY 2022: 6.4×FY 2023: 4.1×FY 2024: 2.1×FY 2025: 1.7×
FY 2016 5y median 4.1× FY 2025
Quick Ratio 1.7×
FY 2016: 1.1×FY 2017: 1.8×FY 2018: 8.7×FY 2019: 3.1×FY 2020: 2.7×FY 2021: 19.4×FY 2022: 6.4×FY 2023: 4.1×FY 2024: 2.1×FY 2025: 1.7×
FY 2016 5y median 4.1× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 0.5×FY 2017: 0.7×FY 2018: 1.7×FY 2019: 0.9×FY 2020: 0.6×FY 2021: 4.6×FY 2022: 2.1×FY 2023: 1.0×FY 2024: 0.5×FY 2025: 0.4×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31